<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3843656</article-id><article-id pub-id-type="pmid">24312163</article-id><article-id pub-id-type="publisher-id">PONE-D-13-14098</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0072892</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>No Evidence of Association between Common Autoimmunity STAT4 and IL23R Risk Polymorphisms and Non-Anterior Uveitis </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head"><italic>IL23R</italic> and <italic>STAT4</italic> Genetic Variants in Uveitis</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Cénit</surname><given-names>María Carmen</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Márquez</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cordero-Coma</surname><given-names>Miguel</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gorroño-Echebarría</surname><given-names>Marina Begoña</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fonollosa</surname><given-names>Alejandro</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Adán</surname><given-names>Alfredo</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Martínez-Berriotxoa</surname><given-names>Agustín</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Díaz Valle</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pato</surname><given-names>Esperanza</given-names></name><xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Blanco</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cañal</surname><given-names>Joaquín</given-names></name><xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Díaz-Llopis</surname><given-names>Manuel</given-names></name><xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>García Serrano</surname><given-names>José Luis</given-names></name><xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Ramón</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>del Rio</surname><given-names>María José</given-names></name><xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Martín-Villa</surname><given-names>José Manuel</given-names></name><xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Molins</surname><given-names>Blanca</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ortego-Centeno</surname><given-names>Norberto</given-names></name><xref ref-type="aff" rid="aff15">
<sup>15</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Martín</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Instituto de Parasitología y Biomedicina López-Neyra, IPBLN, CSIC, Granada, Spain</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Ophthalmology Department, Hospital de León, León, Spain</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Ophthalmology Department, Hospital Universitario Principe de Asturias, Alcalá de Henares, Spain</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Internal Medicine Department, Hospital de Cruces, Bilbao, Spain</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Ophthalmology Department, Hospital Clinic, Barcelona, Spain</addr-line>
</aff><aff id="aff6">
<label>6</label>
<addr-line>Ophthalmology Department, Hospital Clínico San Carlos, Madrid, Spain</addr-line>
</aff><aff id="aff7">
<label>7</label>
<addr-line>Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain</addr-line>
</aff><aff id="aff8">
<label>8</label>
<addr-line>Rheumatology Department, Hospital Marqués de Valdecilla, IFIMAV, Santander, Spain</addr-line>
</aff><aff id="aff9">
<label>9</label>
<addr-line>Ophthalmology Department, Hospital Marqués de Valdecilla, Santander, Spain</addr-line>
</aff><aff id="aff10">
<label>10</label>
<addr-line>Ophthalmology Department, Hospital Universitario La Fe, Valencia, Spain</addr-line>
</aff><aff id="aff11">
<label>11</label>
<addr-line>Ophthalmology Department, Hospital Clínico San Cecilio, Granada, Spain</addr-line>
</aff><aff id="aff12">
<label>12</label>
<addr-line>Internal Medicine Department, Hospital Carlos Haya, Málaga, Spain</addr-line>
</aff><aff id="aff13">
<label>13</label>
<addr-line>Ophthalmology Department, Hospital Carlos Haya, Málaga, Spain</addr-line>
</aff><aff id="aff14">
<label>14</label>
<addr-line>Immunology Department, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain</addr-line>
</aff><aff id="aff15">
<label>15</label>
<addr-line>Internal Medicine Department, Hospital Clínico San Cecilio, Granada, Spain</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Wallace</surname><given-names>Graham R.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Birmingham, United Kingdom</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>anamaort@ipb.csic.es</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Conceived and designed the experiments: JM MCC AM. </plain></SENT>
<SENT sid="3" pm="."><plain>Performed the experiments: MCC AM. </plain></SENT>
<SENT sid="4" pm="."><plain>Analyzed the data: MCC AM MC-C MBG-E AF AA AM-B DDV EP RB JC MD-L JLGS ER MJR JMM-V BM NO-C JM. </plain></SENT>
<SENT sid="5" pm="."><plain>Contributed reagents/materials/analysis tools: MC-C MBG-E AF AA AM-B DDV EP RB JC MD-L JLGS ER MJR JMM-V BM NO-C JM. </plain></SENT>
<SENT sid="6" pm="."><plain>Wrote the manuscript: MCC AM. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>29</day><month>11</month><year>2013</year></pub-date><volume>8</volume><issue>11</issue><elocation-id>e72892</elocation-id><history><date date-type="received"><day>5</day><month>4</month><year>2013</year></date><date date-type="accepted"><day>15</day><month>7</month><year>2013</year></date></history><permissions><copyright-statement>© 2013 Cénit et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Cénit et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec sec-type="headed"><title><text><SENT sid="7" pm="."><plain>Objective </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="8" pm="."><plain>STAT4 and IL23R loci represent common susceptibility genetic factors in autoimmunity. </plain></SENT>
<SENT sid="9" pm="."><plain>We decided to investigate for the first time the possible role of different STAT4/IL23R autoimmune disease-associated polymorphisms on the susceptibility to develop non-anterior uveitis and its main clinical phenotypes. </plain></SENT>
</text></SecTag></p></sec><sec sec-type="headed"><title><text><SENT sid="10" pm="."><plain>Methods </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="11" pm="."><plain>Four functional polymorphisms (rs3821236, rs7574865, rs7574070, and rs897200) located within STAT4 gene as well as three independent polymorphisms (rs7517847, rs11209026, and rs1495965) located within IL23R were genotyped using TaqMan® allelic discrimination in a total of 206 patients with non-anterior uveitis and 1553 healthy controls from Spain. </plain></SENT>
</text></SecTag></p></sec><sec sec-type="headed"><title><text><SENT sid="12" pm="."><plain>Results </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="13" pm="."><plain>No statistically significant differences were found when allele and genotype distributions were compared between non-anterior uveitis patients and controls for any STAT4 (rs3821236: P=0.39, OR=1.12, CI 95%=0.87-1.43; rs7574865: P=0.59 OR=1.07, CI 95%=0.84-1.37; rs7574070: P=0.26, OR=0.89, CI 95%=0.72-1.10; rs897200: P=0.22, OR=0.88, CI 95%=0.71-1.08;) or IL23R polymorphisms (rs7517847: P=0.49, OR=1.08, CI 95%=0.87-1.33; rs11209026: P=0.26, OR=0.78, CI 95%=0.51-1.21; rs1495965: P=0.51, OR=0.93, CI 95%=0.76-1.15). </plain></SENT>
</text></SecTag></p></sec><sec sec-type="headed"><title><text><SENT sid="14" pm="."><plain>Conclusion </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="15" pm="."><plain>Our results do not support a relevant role, similar to that described for other autoimmune diseases, of IL23R and STAT4 polymorphisms in the non-anterior uveitis genetic predisposition. </plain></SENT>
<SENT sid="16" pm="."><plain>Further studies are needed to discard a possible weak effect of the studied variant. </plain></SENT>
</text></SecTag></p></sec></abstract><funding-group><funding-statement>The authors have no support or funding to report.</funding-statement></funding-group></article-meta></front><body><SecTag type="INTRO"><sec sec-type="introduction" id="s1"><title><text><SENT sid="17" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="18" pm="."><plain>Uveitis can be defined as any inflammation affecting the uveal tract, the middle vascular layer of the eye, although in the clinical practice this term includes any intraocular inflammatory process [1]. </plain></SENT>
<SENT sid="19" pm="."><plain>The prevalence of uveitis is estimated at 38 cases per 100,000 people, although it depends on the geographic area [1]. </plain></SENT>
<SENT sid="20" pm="."><plain>This condition is considered a major source of visual impairment as well as an important socio-economic problem, being the fourth cause of blindness on the worldwide [2]. </plain></SENT>
<SENT sid="21" pm="."><plain>There are different forms of uveitis, including either uveitis triggered by a wide range of exogenous (infectious and traumatism) or endogenous agents (non-infectious uveitis related with inflammatory or autoimmune processes) [3]. </plain></SENT>
<SENT sid="22" pm="."><plain>In addition, uveitis patients are frequently classified according to the anatomical location of the inflammation into anterior uveitis (AU), the most common form which represents 60% of cases, intermediate uveitis (IU) (5-13%), posterior uveitis (PU) (15%) and panuveitis or also called diffuse uveitis (PAN) (20%) [4]. </plain></SENT>
</text></p><p><text><SENT sid="23" pm="."><plain>Endogenous uveitis is an inflammatory response triggered by certain environmental factors in individuals with a particular genetic component and it is mainly mediated by immune system driven for a loss of tolerance against self antigens [3]. </plain></SENT>
<SENT sid="24" pm="."><plain>So far, certain HLA alleles have been strongly associated with the uveitis predisposition [5,6,7,8]. </plain></SENT>
<SENT sid="25" pm="."><plain>However, the effect of these alleles just explains a small part of the uveitis heritability and different studies have recently highlighted the implication of non-HLA genetic factors in the susceptibility to this condition [9,10,11]. </plain></SENT>
</text></p><p><text><SENT sid="26" pm="."><plain>There is a well established knowledge that most autoimmune diseases share a certain percentage of their genetic component, showing that some pathologies may be influenced by common pathways [12,13]. </plain></SENT>
<SENT sid="27" pm="."><plain>Genes encoding signal transducer and activator of transcription 4 (STAT4) and interleukin 23 receptor (IL23R) belong to the well established group of risk factors shared by different conditions that influence the breakdown of self-tolerance [13]. </plain></SENT>
<SENT sid="28" pm="."><plain>STAT4 and IL23R are strongly involved in the control of the immune system through of the development and perpetuation of Th17 immune responses [14], which display a dominant role in autoimmunity-associated inflammation [15]. </plain></SENT>
</text></p><p><text><SENT sid="29" pm="."><plain>Different studies have identified IL23R as a susceptibility factor associated to multiple inflammatory conditions [16,17,18]. </plain></SENT>
<SENT sid="30" pm="."><plain>In these studies several independent signals located within IL23R locus were suggested; however, only the R381Q (rs11209026) polymorphism, whose minor allele plays a protective role for several autoimmune disease, appear to have a functional involvement [19,20]. </plain></SENT>
<SENT sid="31" pm="."><plain>Additionally, the rs1495965 polymorphism has been reported as the stronger IL23R association with Behçet’s disease (BD), a systemic autoimmune disease involving uveitis, in a previous combined meta-analysis of two genome-wide association studies (GWASs) [21,22]. </plain></SENT>
<SENT sid="32" pm="."><plain>On the other hand, STAT4 has been also identified as another shared susceptibility locus [23,24]. </plain></SENT>
<SENT sid="33" pm="."><plain>Interestingly, the presence of two STAT4 independent functional genetic variants associated with systemic lupus erythematosus (SLE), both affecting the STAT4 levels, has been recently evidenced by fine mapping [25]. </plain></SENT>
<SENT sid="34" pm="."><plain>Furthermore, two functional polymorphisms located at STAT4 gene have been recently implicated in BD susceptibility by GWASs [26,27]. </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>Recent data have suggested that autoimmune uveitis also seems to share common genetic factors with other autoimmune disorders although these remain unknown yet [28]. </plain></SENT>
<SENT sid="36" pm="."><plain>Taking into account all of the above, we herein aimed to investigate whether the STAT4 and IL23R autoimmune disease-associated polymorphisms are involved in the genetic predisposition to autoimmune uveitis. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s2"><title><text><SENT sid="37" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="s2.1"><title><text><SENT sid="38" pm="."><plain>Study population </plain></SENT>
</text></title><sec id="s2.1.1"><title><text><SENT sid="39" pm="."><plain>Ethics statement </plain></SENT>
</text></title><p><text><SENT sid="40" pm="."><plain>A subject’s written consent was obtained according to the declaration of Helsinki, and the design of the work was approved by the Ethics Committee of Granada (Spain). </plain></SENT>
<SENT sid="41" pm="."><plain>The Ethics Committees of the Hospital de León (León), Hospital Universitario Príncipe de Asturias (Alcalá de Henares), Hospital de Cruces (Bilbao), Hospital Clinic (Barcelona), Hospital Clínico San Carlos (Madrid), Hospital Marqués de Valdecilla (Santander), Hospital Universitario La Fe (Valencia), Hospital Clínico San Cecilio (Granada) and Hospital Carlos Haya (Málaga) also approved the study. </plain></SENT>
</text></p><p><text><SENT sid="42" pm="."><plain>A total of 206 patients with endogenous non anterior uveitis, excluding the uveitis forms associated with systemic immune-mediated diseases except the Vogt-Koyanagi-Harada syndrome, and 1553 ethnically matched healthy controls, all of them of Caucasian origin, were included in the present study. </plain></SENT>
<SENT sid="43" pm="."><plain>The main clinical and demographic characteristics of uveitis patients included in the present study are described in Table 1 . </plain></SENT>
<SENT sid="44" pm="."><plain>The intraocular inflammation seen in patients included intermediate uveitis (24.8%), posterior uveitis (50.0%), and panuveitis (25.2%). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0072892-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0072892.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="45" pm="."><plain>Clinical and demographic features of uveitis patients. </plain></SENT>
</text></title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"><text><SENT sid="46" pm="."><plain>General characteristics of uveitis patients </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="47" pm="."><plain>All patients n=206 </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>Female (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="49" pm="."><plain>126 (61.2) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>Age (mean ± SD) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>47.3 ± 16.9 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>Intermediate Uveitis (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>51 (24.8) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>Posterior Uveitis (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>103 (50.0) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>Panuveitis (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>52 (25.2) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>Bilateral affection (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>153 (74.3) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>Vitritis (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>135 (65.5) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>Macular edema (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>92 (44.7) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>Retinal vasculitis (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>87 (42.2) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>Choroidal neovascularization (%) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>16 (7.8) </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag></sec></sec><sec id="s2.2"><title><text><SENT sid="68" pm="."><plain>Genotyping </plain></SENT>
</text></title><p><text><SENT sid="69" pm="."><plain>Genomic DNA was extracted from peripheral white blood cells and saliva following standard procedures. </plain></SENT>
<SENT sid="70" pm="."><plain>The single-nucleotide polymorphisms (SNPs) were genotyped using pre-designed TaqMan® allelic discrimination assays in a 7900HT Real-Time polymerase chain reaction (PCR) System from Applied Biosystems under conditions recommended by the manufacturer (Foster City, CA, USA). </plain></SENT>
</text></p><p><text><SENT sid="71" pm="."><plain>Since the aim of this study was to investigate whether different STAT4/IL23R autoimmune disease-associated polymorphisms were also implicated in the susceptibility to develop non-anterior uveitis, the IL23R and STAT4 polymorphisms most robustly associated with autoimmunity were selected. </plain></SENT>
<SENT sid="72" pm="."><plain>Following this criterion, we studied the IL23R rs11209026 genetic variant, encoding the functional amino-acid change Arg381Gln [16,17,18,19,20], and two independent STAT4 SNPs (rs3821236 and rs7574865), influencing levels of the protein [23,24,25]. </plain></SENT>
<SENT sid="73" pm="."><plain>Additionally, two IL23R polymorphisms were analyzed; rs7517847, strongly associated with Crohn’s disease and whose association seems to be independent on rs11209026 [16], and, rs1495965, previously associated with BD by GWASs [21,22]. </plain></SENT>
<SENT sid="74" pm="."><plain>On the other hand, two STAT4 genetic variants, rs7574070 and rs897200, recently associated with BD, were included in the study [26,27]. </plain></SENT>
<SENT sid="75" pm="."><plain>Both polymorphisms seem to have functional consequences and are located in a different linkage disequilibrium block from the SNPs rs3821236 and rs7574865. </plain></SENT>
</text></p></sec><sec id="s2.3"><title><text><SENT sid="76" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="77" pm="."><plain>The overall statistical power of the analysis, according to Power Calculator for Genetic Studies 2006 software (http://www.sph.umich.edu/csg/abecasis/CaTS/), is shown in Table S1 . </plain></SENT>
<SENT sid="78" pm="."><plain>The genotype, allele and carrier frequencies were compared between patients, subgroup of patients and controls applying χ2 test and/or Fisher’s exact test. </plain></SENT>
<SENT sid="79" pm="."><plain>The Linux software plink (v1.07) (http://pngu.mgh.harvard.edu/purcell/plink/) was used to perform 2 × 2 contingency tables and χ2 test and/or Fisher’s exact test when it was necessary. </plain></SENT>
<SENT sid="80" pm="."><plain>Odds ratios (OR) and 95% confidence intervals (CI) were obtained according to Woolf’s method. </plain></SENT>
<SENT sid="81" pm="."><plain>Hardy-Weinberg equilibrium (HWE) was tested for all SNPs at significance level=0.01. P-values below 0.05 were considered as statistically significant. </plain></SENT>
</text></p><p><text><SENT sid="82" pm="."><plain>Furthermore, the effect of the analyzed genetic variants was analyzed either in isolation or in allelic combination analysis. </plain></SENT>
<SENT sid="83" pm="."><plain>The allelic combination frequencies were estimated using plink (v1.07) and Haploview (V. </plain></SENT>
<SENT sid="84" pm="."><plain>4.2). </plain></SENT>
</text></p><p><text><SENT sid="85" pm="."><plain>Possible interactions between genes were evaluated following two different approaches: using logistic regression and by analyzing the distribution of genotypes for one SNP in cases conditioned by genotypes for the other SNP located in different gene. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="s3"><title><text><SENT sid="86" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="87" pm="."><plain>Genotypic and allelic frequencies in cases and controls are shown in Table 2 . </plain></SENT>
<SENT sid="88" pm="."><plain>No statistically significant deviation from Hardy-Weinberg equilibrium (P≤0.01) was observed for all the studied SNPs in the control set and the frequencies of the analyzed SNPs were in agreement with the data of the HapMap project. </plain></SENT>
<SENT sid="89" pm="."><plain>Genotyping success rate was higher than 99% for all analyzed SNPs. </plain></SENT>
<SENT sid="90" pm="."><plain>In addition, randomly selected samples were genotyped twice to verify the genotyping accuracy and 99% of the genotypes were identical. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0072892-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0072892.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="91" pm="."><plain>Genotype and minor allele frequencies of IL23R and STAT4 genetic variants in uveitis patients and healthy controls. </plain></SENT>
</text></title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>Genotype, N (%) </plain></SENT>
</text></th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1"><text><SENT sid="93" pm="."><plain>Allele test  </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>SNP </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>1/2 </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>Subgroup (n) </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>1/1 </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>1/2 </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>2/2 </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>MAF (%) </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>P -value* </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>OR [CI 95%]** </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>IL23R </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>rs7517847 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>G/T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>267 (17.26) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>732 (47.32) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>548 (35.42) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>40.92 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>Non anterior Uveitis (n=206) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>41 (19.90) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>94 (45.63) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>71 (34.47) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>42.72 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>0.49 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>1.08 (0.87-1.33) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>rs11209026 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>A/G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>8 (0.52) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>211 (13.64) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>1328 (85.84) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>7.34 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>Non anterior Uveitis (n=206) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>0 (0.00) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>24 (11.65) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>182 (88.35) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>5.83 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>0.26 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>0.78 (0.51-1.21) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>rs1495965 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>C/T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>326 (21.07) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>738 (47.71) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>483 (31.22) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>44.93 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>Non anterior Uveitis (n=206) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>44 (21.36) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>90 (43.69) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>72 (34.95) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>43.20 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>0.51 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>0.93 (0.76-1.15) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>STAT4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>rs3821236 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>A/G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>65 (4.20) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>504 (32.58) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>978 (63.22) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>20.49 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>Non anterior Uveitis (n=206) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>10 (4.85) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>72 (34.95) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>124 (60.19) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>22.33 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>0.39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>1.12 (0.87-1.43) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>rs7574865 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>T/G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>72 (4.65) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>533 (34.45) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>942 (60.89) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>21.88 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>Non anterior Uveitis (n=206) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>8 (3.88) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>79 (38.35) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>119 (57.77) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>23.06 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>0.59 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>1.07 (0.84-1.37) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>rs7574070 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>A/C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>247 (15.97) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>754 (48.74) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>546 (35.29) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>40.34 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>Non anterior Uveitis (n=203) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>29 (14.29) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>94 (46.31) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>80 (39.41) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>37.44 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>0.26 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>0.89 (0.72-1.10) </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="189" pm="."><plain>rs897200 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>T/C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>Controls (n=1547) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>277 (17.91) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>759 (49.06) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>511 (33.03) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>42.44 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>Non anterior Uveitis (n=205) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>33 (16.10) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>95 (46.34) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>77 (37.56) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>39.27 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>0.22 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>0.88 (0.71-1.08) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="203" pm="."><plain>*All P-values have been calculated for the allelic model; **Odds ratio for the minor allele. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="204" pm="."><plain>As shown in Table 2 , when genotype, allele and carriers frequencies for the analyzed STAT4 and IL23R SNPs were compared between non-anterior uveitis patients and controls, no association with the global disease susceptibility was observed for any of the analyzed polymorphisms. </plain></SENT>
<SENT sid="205" pm="."><plain>Similarly, when we compared the different subgroups of non-anterior uveitis patients stratified according to the different clinical features showed in Table 1  no statistically significant differences were detected (data not shown). </plain></SENT>
</text></p><p><text><SENT sid="206" pm="."><plain>On the other hand, the allelic combination analysis of the studied polymorphisms located within the IL23R locus as well as within the STAT4 gene did not provide further information (data not shown). </plain></SENT>
</text></p><p><text><SENT sid="207" pm="."><plain>Furthermore, since STAT4 and IL23R are molecules of the same pathway, we decided to study the possible interaction between the analyzed IL23R and STAT4 genetic variants; however, no interaction between them was observed (data not shown). </plain></SENT>
</text></p></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="s4"><title><text><SENT sid="208" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="209" pm="."><plain>No large-scale genome-wide association studies in uveitis have been published to date, and only few genetic studies, focused mainly on anterior uveitis, have been conducted to identify the uveitis genetic component [9,10,11]. </plain></SENT>
<SENT sid="210" pm="."><plain>Indeed, only some HLA alleles have been strongly associated with uveitis predisposition [5,6,7,8], and genetic factors outside HLA region influencing uveitis susceptibility remain unknown. </plain></SENT>
</text></p><p><text><SENT sid="211" pm="."><plain>Autoimmune uveitis pathogenesis seems to be mainly mediated by a T cell-driven cellular immune response [29]. </plain></SENT>
<SENT sid="212" pm="."><plain>Uveitis condition was traditionally considered as a Th1 mediated trait [30]; however, cumulating knowledge suggests that IL-23, rather than IL-12, is necessary for experimental autoimmune uveitis (EAU) induction [31]. </plain></SENT>
<SENT sid="213" pm="."><plain>Indeed, Th17 cells, whose development in human is mainly induced in response to IL-23 and IL-1β [14], release interleukin-17A that exhibits potent proinflammatory properties in animal models of autoimmunity, including EAU [32]. </plain></SENT>
<SENT sid="214" pm="."><plain>In this IL-23/IL-17 axis, STAT4 is required for the signal transduction of IL-23 and, consequently is involved in the development of Th17 cells [33]. </plain></SENT>
</text></p><p><text><SENT sid="215" pm="."><plain>Considering the shared genetic component among the different immune-mediated diseases, including the autoimmune uveitis [12,13,28], and the key role that Th17 responses play in the uveitis pathogenesis, we speculated that STAT4 and IL23R, two general autoimmunity loci, may contribute to the non-anterior uveitis susceptibility. </plain></SENT>
</text></p><p><text><SENT sid="216" pm="."><plain>However, our results evidenced no association of any analyzed STAT4 and IL23R genetic variants with either the non-anterior uveitis or with the studied clinical subphenotypes. </plain></SENT>
<SENT sid="217" pm="."><plain>Regarding IL23R, the statistical power of our study to detect the described odds ratios in previous GWASs on different autoimmune diseases [16,34,35] was higher than 80%, considering the strong effect sizes observed in those studies for the analyzed IL23R variants (Table 3 ). It could be speculated that the effect size of the analyzed IL23R polymorphisms was similar in non-anterior uveitis than in other autoimmune diseases. </plain></SENT>
<SENT sid="219" pm="."><plain>In this case, it is not likely that the lack of association was due to a type II error. </plain></SENT>
<SENT sid="220" pm="."><plain>Likewise, based on the statistical power of our study, an effect of the STAT4 rs897200 and rs7574070 genetic variants similar to that described for BD [26,27] could be discarded in non-anterior uveitis (Table 3 ). In relation to the STAT4 rs3821236 and rs7574865 polymorphisms, there was a higher heterogeneity in the reported ORs [36,37,38,39,40] (Table 3 ), with some autoimmune diseases showing considerably stronger signals than others (e.g. OR &gt; 1.40 for SLE and 1.16 for RA). </plain></SENT>
<SENT sid="222" pm="."><plain>Therefore, no definitive conclusions on these STAT4 variants can be drawn. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0072892-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0072892.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="223" pm="."><plain>Statistical power of the present study accordingly with the described odds ratios for different autoimmune diseases in previous genome-wide association studies. </plain></SENT>
</text></title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>Disease </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>OR *  </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>Statistical power </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>IL23R </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>rs7517847 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>IBD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>0.62 [16] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>0.99 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>rs11209026 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>CD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>0.38 [34] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>1.00 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>UC </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>0.57 [35] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="238" pm="."><plain>0.86 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="239" pm="."><plain>AS </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="240" pm="."><plain>0.60 [45] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="241" pm="."><plain>0.78 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="242" pm="."><plain>rs1495965 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>BD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>1.35 [21] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>0.81 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>STAT4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>rs3821236 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>SSc </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>1.30 [39] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>0.53 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>SLE </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>1.49 [38] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>0.89 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>rs7574865 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>SSc </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>1.38 [36] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>0.74 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>SLE </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>1.49 [37] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>0.91 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>RA </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>1.16 [40] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>0.21 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>rs7574070 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>BD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="266" pm="."><plain>1.40 [26]/1.27 [27] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="267" pm="."><plain>0.88/0.61 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="268" pm="."><plain>rs897200 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="269" pm="."><plain>BD </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="270" pm="."><plain>1.45 [41] </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="271" pm="."><plain>0.94 </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="ngtab3.1"><p><text><SENT sid="272" pm="."><plain>* Odds ratio for the minor allele. </plain></SENT>
</text></p></fn><fn><p><text><SENT sid="273" pm="."><plain>IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis; AS, ankylosing spondylitis; BD, Behçet’s disease; SSc, systemic sclerosis; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="274" pm="."><plain>On the other hand, associations of these IL23R and STAT4 polymorphisms with systemic autoimmune diseases involving uveitis, such as Behçet’s disease, Vogt-Koyanagi-Harada disease or sarcoidosis, have been described in Asian populations [21,22,26,27,41,42,43,44] but not in Europeans. </plain></SENT>
<SENT sid="275" pm="."><plain>The allele frequencies of controls in our study are similar to those described in Asian populations. </plain></SENT>
<SENT sid="276" pm="."><plain>Therefore, the lack of association of these polymorphisms with non-anterior uveitis in the Spanish population may be due to a differential genetic background of this disease among ethnicities rather than differences in allele frequencies. </plain></SENT>
<SENT sid="277" pm="."><plain>Hence, these genes may not be uveitis risk factors in populations of European ancestry. </plain></SENT>
</text></p><p><text><SENT sid="278" pm="."><plain>In conclusion, our data do not support a relevant role of IL23R and STAT4 polymorphisms in the genetic susceptibility to develop non-anterior uveitis. </plain></SENT>
<SENT sid="279" pm="."><plain>As limitation, our study presents a moderate statistical power due to the low prevalence of endogenous non-anterior uveitis in Caucasian population. </plain></SENT>
<SENT sid="280" pm="."><plain>Hence, a possible weak effect of the studied variants in disease predisposition or phenotype expression may not be discarded and, hence, additional studies in larger independent cohorts would be desirable. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material"><title><text><SENT sid="281" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0072892.s001"><label>Table S1</label><caption><p><text><SENT sid="282" pm="."><plain>Overall statistical power of the study for each analyzed IL23R and STAT4 genetic variant at the 5% significance level. </plain></SENT>
</text></p><p><text><SENT sid="283" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0072892.s001.docx"><caption><p><text><SENT sid="284" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="285" pm="."><plain>The authors thank Sofía Vargas, Sonia García and Gema Robledo (from Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, Spain) for their excellent technical assistance, and all the patients and healthy controls for kindly accepting their essential collaboration. </plain></SENT>
<SENT sid="286" pm="."><plain>Banco Nacional de ADN (University of Salamanca, Spain) and Biobanco Vasco para la Investigación (Fundación Vasca de Innovación e Investigación Sanitarias, Bizkaia, Spain) are thanked for supplying part of the samples. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="B1"><text><SENT sid="287" pm="."><plain>1 WakefieldD, ChangJH (2005) Epidemiology of uveitis. Int Ophthalmol Clin 45: 1-13. doi:10.1097/01.iio.0000155938.83083.94. </plain></SENT>
<SENT sid="288" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/15791154">15791154</ext-link>. </plain></SENT>
</text></ref><ref id="B2"><text><SENT sid="289" pm="."><plain>2 RothovaA, Suttorp-van SchultenMS, Frits TreffersW, KijlstraA (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80: 332-336. doi:10.1136/bjo.80.4.332. </plain></SENT>
<SENT sid="290" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8703885">8703885</ext-link>.8703885 </plain></SENT>
</text></ref><ref id="B3"><text><SENT sid="291" pm="."><plain>3 LevyRA, de AndradeFA, FoeldvariI (2011) Cutting-edge issues in autoimmune uveitis. Clin Rev Allergy Immunol 41: 214-223. doi:10.1007/s12016-011-8267-x. </plain></SENT>
<SENT sid="292" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21913066">21913066</ext-link>.21913066 </plain></SENT>
</text></ref><ref id="B4"><text><SENT sid="293" pm="."><plain>4 DeschenesJ, MurrayPI, RaoNA, NussenblattRB (2008) International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm 16: 1-2. doi:10.1080/09273940801899822. </plain></SENT>
<SENT sid="294" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18379933">18379933</ext-link>.18379933 </plain></SENT>
</text></ref><ref id="B5"><text><SENT sid="295" pm="."><plain>5 BrewertonDA, CaffreyM, NichollsA, WaltersD, JamesDC (1973) Acute anterior uveitis and HL-A 27. Lancet 302: 994-996. doi:10.1016/S0140-6736(73)91090-8. </plain></SENT>
<SENT sid="296" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/4127279">4127279</ext-link>.4127279 </plain></SENT>
</text></ref><ref id="B6"><text><SENT sid="297" pm="."><plain>6 LeHoangP, OzdemirN, BenhamouA, TabaryT, EdelsonC et al. (1992) HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol 113: 33-35. </plain></SENT>
<SENT sid="298" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/1728143">1728143</ext-link>.1728143 </plain></SENT>
</text></ref><ref id="B7"><text><SENT sid="299" pm="."><plain>7 ShindoY, OhnoS, YamamotoT, NakamuraS, InokoH (1994) Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 39: 169-176. doi:10.1016/0198-8859(94)90257-7. </plain></SENT>
<SENT sid="300" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8026985">8026985</ext-link>.8026985 </plain></SENT>
</text></ref><ref id="B8"><text><SENT sid="301" pm="."><plain>8 OrucS, DuffyBF, MohanakumarT, KaplanHJ (2001) The association of HLA class II with pars planitis. Am J Ophthalmol 131: 657-659. doi:10.1016/S0002-9394(00)00863-1. </plain></SENT>
<SENT sid="302" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11336946">11336946</ext-link>.11336946 </plain></SENT>
</text></ref><ref id="B9"><text><SENT sid="303" pm="."><plain>9 ChenY, VaughanRW, KondeatisE, FortuneF, GrahamEM et al. (2004) Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 63: 41-45. doi:10.1111/j.1399-0039.2004.00150.x. </plain></SENT>
<SENT sid="304" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/14651522">14651522</ext-link>.14651522 </plain></SENT>
</text></ref><ref id="B10"><text><SENT sid="305" pm="."><plain>10 WallaceGR, KondeatisE, VaughanRW, VerityDH, ChenY et al. (2007) IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol 68: 122-127. doi:10.1016/j.humimm.2006.11.010. </plain></SENT>
<SENT sid="306" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17321902">17321902</ext-link>.17321902 </plain></SENT>
</text></ref><ref id="B11"><text><SENT sid="307" pm="."><plain>11 AtanD, Fraser-BellS, PlskovaJ, KuffovaL, HoganA et al. (2010) Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci 51: 4133-4142. doi:10.1167/iovs.09-4583. </plain></SENT>
<SENT sid="308" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20335604">20335604</ext-link>.20335604 </plain></SENT>
</text></ref><ref id="B12"><text><SENT sid="309" pm="."><plain>12 ZhernakovaA, van DiemenCC, WijmengaC (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10: 43-55. doi:10.1038/nrg2489. </plain></SENT>
<SENT sid="310" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19092835">19092835</ext-link>.19092835 </plain></SENT>
</text></ref><ref id="B13"><text><SENT sid="311" pm="."><plain>13 ChoJH, GregersenPK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365: 1612-1623. doi:10.1056/NEJMra1100030. </plain></SENT>
<SENT sid="312" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22029983">22029983</ext-link>.22029983 </plain></SENT>
</text></ref><ref id="B14"><text><SENT sid="313" pm="."><plain>14 WilsonNJ, BonifaceK, ChanJR, McKenzieBS, BlumenscheinWM et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8: 950-957. doi:10.1038/nrg2199. </plain></SENT>
<SENT sid="314" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17676044">17676044</ext-link>.17676044 </plain></SENT>
</text></ref><ref id="B15"><text><SENT sid="315" pm="."><plain>15 BettelliE, OukkaM, KuchrooVK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8: 345-350. doi:10.1038/nrm2164. </plain></SENT>
<SENT sid="316" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17375096">17375096</ext-link>.17375096 </plain></SENT>
</text></ref><ref id="B16"><text><SENT sid="317" pm="."><plain>16 DuerrRH, TaylorKD, BrantSR, RiouxJD, SilverbergMS et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. doi:10.1126/science.1135245. </plain></SENT>
<SENT sid="318" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17068223">17068223</ext-link>.17068223 </plain></SENT>
</text></ref><ref id="B17"><text><SENT sid="319" pm="."><plain>17 BurtonPR, ClaytonDG, CardonLR, CraddockN, DeloukasP et al. (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39: 1329-1337. doi:10.1038/ng.2007.17. </plain></SENT>
<SENT sid="320" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17952073">17952073</ext-link>.17952073 </plain></SENT>
</text></ref><ref id="B18"><text><SENT sid="321" pm="."><plain>18 CargillM, SchrodiSJ, ChangM, GarciaVE, BrandonR et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273-290. doi:10.1086/511051. </plain></SENT>
<SENT sid="322" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17236132">17236132</ext-link>.17236132 </plain></SENT>
</text></ref><ref id="B19"><text><SENT sid="323" pm="."><plain>19 Di MeglioP, Di CesareA, LaggnerU, ChuCC, NapolitanoL et al. (2011) The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLOS ONE 6: e17160. doi:10.1371/journal.pone.0017160. </plain></SENT>
<SENT sid="324" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21364948">21364948</ext-link>.21364948 </plain></SENT>
</text></ref><ref id="B20"><text><SENT sid="325" pm="."><plain>20 PidashevaS, TrifariS, PhillipsA, HackneyJA, MaY et al. (2011) Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLOS ONE 6: e25038. doi:10.1371/journal.pone.0025038. </plain></SENT>
<SENT sid="326" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22022372">22022372</ext-link>.22022372 </plain></SENT>
</text></ref><ref id="B21"><text><SENT sid="327" pm="."><plain>21 MizukiN, MeguroA, OtaM, OhnoS, ShiotaT et al. (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 42: 703-706. doi:10.1038/ng.624. </plain></SENT>
<SENT sid="328" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20622879">20622879</ext-link>.20622879 </plain></SENT>
</text></ref><ref id="B22"><text><SENT sid="329" pm="."><plain>22 RemmersEF, CosanF, KirinoY, OmbrelloMJ, AbaciN et al. (2010) Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 42: 698-702. doi:10.1038/ng.625. </plain></SENT>
<SENT sid="330" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20622878">20622878</ext-link>.20622878 </plain></SENT>
</text></ref><ref id="B23"><text><SENT sid="331" pm="."><plain>23 RemmersEF, PlengeRM, LeeAT, GrahamRR, HomG et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357: 977-986. doi:10.1056/NEJMoa073003. </plain></SENT>
<SENT sid="332" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17804842">17804842</ext-link>.17804842 </plain></SENT>
</text></ref><ref id="B24"><text><SENT sid="333" pm="."><plain>24 Palomino-MoralesRJ, Diaz-GalloLM, WitteT, AnayaJM, MartínJ (2010) Influence of STAT4 polymorphism in primary Sjogren's syndrome. J Rheumatol 37: 1016-1019. doi:10.3899/jrheum.091007. </plain></SENT>
<SENT sid="334" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20360187">20360187</ext-link>.20360187 </plain></SENT>
</text></ref><ref id="B25"><text><SENT sid="335" pm="."><plain>25 AbelsonAK, Delgado-VegaAM, KozyrevSV, SánchezE, Velázquez-CruzR et al. (2009) STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 68: 1746-1753. doi:10.1136/ard.2008.097642. </plain></SENT>
<SENT sid="336" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19019891">19019891</ext-link>.19019891 </plain></SENT>
</text></ref><ref id="B26"><text><SENT sid="337" pm="."><plain>26 HouS, YangZ, DuL, JiangZ, ShuQ et al. (2012) Identification of a susceptibility locus in STAT4 for Behcet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum 64: 4104-4113. doi:10.1002/art.37708. </plain></SENT>
<SENT sid="338" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23001997">23001997</ext-link>.23001997 </plain></SENT>
</text></ref><ref id="B27"><text><SENT sid="339" pm="."><plain>27 KirinoY, BertsiasG, IshigatsuboY, MizukiN, Tugal-TutkunI et al. (2013) Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45: 202-207. doi:10.1038/ng.2520. </plain></SENT>
<SENT sid="340" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/23291587">23291587</ext-link>.23291587 </plain></SENT>
</text></ref><ref id="B28"><text><SENT sid="341" pm="."><plain>28 MattapallilMJ, SahinA, SilverPB, SunSH, ChanCC et al. (2008) Common genetic determinants of uveitis shared with other autoimmune disorders. J Immunol 180: 6751-6759. </plain></SENT>
<SENT sid="342" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18453595">18453595</ext-link>.18453595 </plain></SENT>
</text></ref><ref id="B29"><text><SENT sid="343" pm="."><plain>29 HoraiR, CaspiRR (2011) Cytokines in autoimmune uveitis. J Interferon Cytokine Res 31: 733-744. doi:10.1089/jir.2011.0042. </plain></SENT>
<SENT sid="344" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21787221">21787221</ext-link>.21787221 </plain></SENT>
</text></ref><ref id="B30"><text><SENT sid="345" pm="."><plain>30 XuH, RizzoLV, SilverPB, CaspiRR (1997) Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 178: 69-78. doi:10.1006/cimm.1997.1121. </plain></SENT>
<SENT sid="346" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/9184700">9184700</ext-link>.9184700 </plain></SENT>
</text></ref><ref id="B31"><text><SENT sid="347" pm="."><plain>31 LugerD, SilverPB, TangJ, CuaD, ChenZ et al. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205: 799-810. doi:10.1084/jem.20071258. </plain></SENT>
<SENT sid="348" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18391061">18391061</ext-link>.18391061 </plain></SENT>
</text></ref><ref id="B32"><text><SENT sid="349" pm="."><plain>32 Amadi-ObiA, YuCR, LiuX, MahdiRM, ClarkeGL et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718. doi:10.1038/nm1585. </plain></SENT>
<SENT sid="350" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17496900">17496900</ext-link>.17496900 </plain></SENT>
</text></ref><ref id="B33"><text><SENT sid="351" pm="."><plain>33 MathurAN, ChangHC, ZisoulisDG, StriteskyGL, YuQ et al. (2007) Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178: 4901-4907. </plain></SENT>
<SENT sid="352" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/17404271">17404271</ext-link>.17404271 </plain></SENT>
</text></ref><ref id="B34"><text><SENT sid="353" pm="."><plain>34 BarrettJC, HansoulS, NicolaeDL, ChoJH, DuerrRH et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962. doi:10.1038/ng.175. </plain></SENT>
<SENT sid="354" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/18587394">18587394</ext-link>.18587394 </plain></SENT>
</text></ref><ref id="B35"><text><SENT sid="355" pm="."><plain>35 AndersonCA, BoucherG, LeesCW, FrankeA, D'AmatoM et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-252. doi:10.1038/ng.764. </plain></SENT>
<SENT sid="356" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21297633">21297633</ext-link>.21297633 </plain></SENT>
</text></ref><ref id="B36"><text><SENT sid="357" pm="."><plain>36 AllanoreY, SaadM, DieudéP, AvouacJ, DistlerJH et al. (2011) Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 7: e1002091 PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21750679">21750679</ext-link>.21750679 </plain></SENT>
</text></ref><ref id="B37"><text><SENT sid="358" pm="."><plain>37 ChungSA, TaylorKE, GrahamRR, NitithamJ, LeeAT et al. (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7: e1001323 PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21408207">21408207</ext-link>.21408207 </plain></SENT>
</text></ref><ref id="B38"><text><SENT sid="359" pm="."><plain>38 GrahamRR, CotsapasC, DaviesL, HackettR, LessardCJ et al. (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: 1059-1061. doi:10.1038/ng.200. </plain></SENT>
<SENT sid="360" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19165918">19165918</ext-link>.19165918 </plain></SENT>
</text></ref><ref id="B39"><text><SENT sid="361" pm="."><plain>39 RadstakeTR, GorlovaO, RuedaB, MartinJE, AlizadehBZ et al. (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42: 426-429. doi:10.1038/ng.565. </plain></SENT>
<SENT sid="362" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20383147">20383147</ext-link>.20383147 </plain></SENT>
</text></ref><ref id="B40"><text><SENT sid="363" pm="."><plain>40 StahlEA, RaychaudhuriS, RemmersEF, XieG, EyreS et al. (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42: 508-514. doi:10.1038/ng.582. </plain></SENT>
<SENT sid="364" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20453842">20453842</ext-link>.20453842 </plain></SENT>
</text></ref><ref id="B41"><text><SENT sid="365" pm="."><plain>41 HuK, YangP, JiangZ, HouS, DuL et al. (2010) STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behcet's disease. Hum Immunol 71: 723-726. doi:10.1016/j.humimm.2010.04.007. </plain></SENT>
<SENT sid="366" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20438790">20438790</ext-link>.20438790 </plain></SENT>
</text></ref><ref id="B42"><text><SENT sid="367" pm="."><plain>42 JiangZ, YangP, HouS, DuL, XieL et al. (2010) IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 69: 1325-1328. doi:10.1136/ard.2009.119420. </plain></SENT>
<SENT sid="368" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20375120">20375120</ext-link>.20375120 </plain></SENT>
</text></ref><ref id="B43"><text><SENT sid="369" pm="."><plain>43 KimHS, ChoiD, LimLL, AlladaG, SmithJR et al. (2011) Association of interleukin 23 receptor gene with sarcoidosis. Dis Markers 31: 17-24. doi:10.1155/2011/185106. </plain></SENT>
<SENT sid="370" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21846945">21846945</ext-link>.21846945 </plain></SENT>
</text></ref><ref id="B44"><text><SENT sid="371" pm="."><plain>44 XavierJM, ShahramF, DavatchiF, RosaA, CrespoJ et al. (2012) Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behcet's disease. Arthritis Rheum 64: 2761-2772. doi:10.1002/art.34437. </plain></SENT>
<SENT sid="372" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/22378604">22378604</ext-link>.22378604 </plain></SENT>
</text></ref><ref id="B45"><text><SENT sid="373" pm="."><plain>45 ReveilleJD, SimsAM, DanoyP, EvansDM, LeoP et al. (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42: 123-127. doi:10.1038/ng.513. </plain></SENT>
<SENT sid="374" pm="."><plain>PubMed: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20062062">20062062</ext-link>.20062062 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
